GlassScriptPhysician profile
Annmarie Ray
NPI 1699738435
$882.49
in general payments reported to CMS, 2019-2025
18 companies · $121 in 2025
The $121 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $73.37 · 2020: $77.95 · 2021: $176 · 2022: $256 · 2023: $75.54 · 2024: $103 · 2025: $121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $299.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $169.97 | 2021-2025 | |
| Heartflow, INC. | $159.92 | 2022-2023 | Ffrct |
| Braeburn INC. | $97.05 | 2024-2025 | Brixadi |
| Amgen INC. | $71.25 | 2019-2024 | Krystexxa |
| Novo Nordisk INC | $49.40 | 2020-2023 | Rybelsus, Ozempic |
| Lilly USA, LLC | $40.31 | 2020-2025 | Zepbound, Mounjaro |
| Novartis Pharmaceuticals Corporation | $38.60 | 2022 | |
| Pfizer INC. | $34.68 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $33.84 | 2020-2021 | |
| Allergan, INC. | $32.45 | 2020 | |
| Gilead Sciences, INC. | $24.80 | 2025 | Epclusa |
| Biohaven Pharmaceuticals, INC. | $22.63 | 2021 | |
| Indivior INC. | $21.45 | 2025 | Sublocade |
| Upsher-Smith Laboratories LLC | $19.95 | 2019 | |
| Medtronic, INC. | $19.82 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orexo US, INC. | $17.47 | 2025 | |
| Philips North America LLC | $16.25 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $12.65 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Annmarie Ray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.